Anavex Life Sciences (AVXL) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.45% |
| Sep 30, 2025 | 31.25% |
| Jun 30, 2025 | -23.08% |
| Mar 31, 2025 | 7.14% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -7.69% |
| Mar 31, 2024 | -18.18% |
| Dec 31, 2023 | 15.38% |
| Sep 30, 2023 | 7.14% |
| Jun 30, 2023 | 17.65% |
| Mar 31, 2023 | -2.19% |
| Dec 31, 2022 | 10.47% |
| Mar 31, 2017 | 50.00% |
| Dec 31, 2016 | 55.56% |
| Sep 30, 2016 | -200.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 50.00% |
| Dec 31, 2015 | 42.86% |
| Sep 30, 2015 | 4.55% |
| Jun 30, 2015 | -83.33% |
| Mar 31, 2015 | -100.00% |
| Dec 31, 2014 | 93.88% |
| Sep 30, 2014 | -3,166.67% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | -200.00% |
| Dec 31, 2013 | 90.00% |
| Sep 30, 2013 | -900.00% |
| Dec 31, 2012 | 0.00% |
| Sep 30, 2012 | 93.75% |
| Jun 30, 2012 | -433.33% |
| Mar 31, 2012 | 62.50% |
| Dec 31, 2011 | -60.00% |
| Sep 30, 2011 | 16.67% |
| Jun 30, 2011 | 25.00% |
| Mar 31, 2011 | 0.00% |
| Dec 31, 2010 | 38.46% |